Speaker illustration

Doctor Clare Balendran

AstraZeneca, Gothenburg (Sweden)

Polymorphisms of the ALOX5AP gene (5-lipoxygenase activating protein) are associated with increased cardiovascular risk in patients with acute coronary syndrome: Analysis of PLATO genetics sub-study.

Event: ESC Congress 2017

Topic: Genetics and gene therapy

Session: Best Posters in genomics to therapy


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb